Peter Held

1.1k total citations · 1 hit paper
11 papers, 721 citations indexed

About

Peter Held is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Internal Medicine. According to data from OpenAlex, Peter Held has authored 11 papers receiving a total of 721 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 5 papers in Surgery and 4 papers in Internal Medicine. Recurrent topics in Peter Held's work include Antiplatelet Therapy and Cardiovascular Diseases (7 papers), Lipoproteins and Cardiovascular Health (5 papers) and Venous Thromboembolism Diagnosis and Management (4 papers). Peter Held is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (7 papers), Lipoproteins and Cardiovascular Health (5 papers) and Venous Thromboembolism Diagnosis and Management (4 papers). Peter Held collaborates with scholars based in Sweden, Japan and United States. Peter Held's co-authors include Ka Sing Wong, Gregory W. Albers, Hans Denison, Pierre Amarenco, J. Donald Easton, Kazuo Minematsu, Carlos A. Molina, Yongjun Wang, Jenny Jonasson and S. Claiborne Johnston and has published in prestigious journals such as New England Journal of Medicine, Stroke and The Lancet Neurology.

In The Last Decade

Peter Held

11 papers receiving 701 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack

2016 321 citations S. Claiborne Johnston, Pierre Amarenco et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Held Sweden	9	537	295	225	192	131	11	721
Christopher R. Gibbs United Kingdom	14	555 1.0×	93 0.3×	72 0.3×	93 0.5×	102 0.8×	20	768
Jeremy S. Paikin Canada	13	342 0.6×	60 0.2×	173 0.8×	53 0.3×	85 0.6×	18	537
H.C. Diener Germany	8	309 0.6×	145 0.5×	72 0.3×	95 0.5×	115 0.9×	18	444
Waqar Shamim United Kingdom	10	673 1.3×	63 0.2×	39 0.2×	79 0.4×	150 1.1×	16	1.0k
Hiroshige Yamabe Japan	21	872 1.6×	50 0.2×	42 0.2×	67 0.3×	157 1.2×	86	1.1k
Sait Terzi Türkiye	13	309 0.6×	71 0.2×	26 0.1×	82 0.4×	98 0.7×	44	457
Mário Oliveira Portugal	15	1.1k 2.0×	76 0.3×	102 0.5×	42 0.2×	244 1.9×	156	1.2k
Satomi Iwashita Japan	12	592 1.1×	49 0.2×	64 0.3×	104 0.5×	175 1.3×	21	842
Laura Vitali Serdoz Italy	15	810 1.5×	67 0.2×	74 0.3×	72 0.4×	121 0.9×	41	986
Kehui Dong China	12	112 0.2×	254 0.9×	87 0.4×	160 0.8×	35 0.3×	26	415

Countries citing papers authored by Peter Held

Since Specialization

Citations

This map shows the geographic impact of Peter Held's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Held with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Held more than expected).

Fields of papers citing papers by Peter Held

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Held. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Held. The network helps show where Peter Held may publish in the future.

Co-authorship network of co-authors of Peter Held

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Held. A scholar is included among the top collaborators of Peter Held based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Held. Peter Held is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Molina, Carlos A., S. Claiborne Johnston, Per Ladenvall, et al.. (2019). Time to Loading Dose and Risk of Recurrent Events in the SOCRATES Trial. Stroke. 50(3). 675–682. 3 indexed citations

2.

Wong, Ka Sing, Pierre Amarenco, Gregory W. Albers, et al.. (2018). Efficacy and Safety of Ticagrelor in Relation to Aspirin Use Within the Week Before Randomization in the SOCRATES Trial. Stroke. 49(7). 1678–1685. 18 indexed citations

3.

Amarenco, Pierre, Gregory W. Albers, Hans Denison, et al.. (2017). Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial. The Lancet Neurology. 16(4). 301–310. 119 indexed citations

4.

Amarenco, Pierre, Gregory W. Albers, Hans Denison, et al.. (2017). Ticagrelor Versus Aspirin in Acute Embolic Stroke of Undetermined Source. Stroke. 48(9). 2480–2487. 15 indexed citations

5.

Wang, Yongjun, Kazuo Minematsu, Ka Sing Wong, et al.. (2016). Ticagrelor in Acute Stroke or Transient Ischemic Attack in Asian Patients. Stroke. 48(1). 167–173. 18 indexed citations

6.

Johnston, S. Claiborne, Pierre Amarenco, Gregory W. Albers, et al.. (2016). Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack. New England Journal of Medicine. 375(1). 35–43. 321 indexed citations breakdown →

7.

Johnston, S. Claiborne, Pierre Amarenco, Gregory W. Albers, et al.. (2015). Acute Stroke or Transient Ischemic Attack Treated with Aspirin or Ticagrelor and Patient Outcomes (Socrates) Trial: Rationale and Design. International Journal of Stroke. 10(8). 1304–1308. 21 indexed citations

8.

Eriksson, Henry, Lars Frison, Per‐Olof Hansson, et al.. (1999). Pharmacokinetics and Pharmacodynamics of Melagatran, a Novel Synthetic LMW Thrombin Inhibitor, in Patients with Acute DVT. Thrombosis and Haemostasis. 81(3). 358–363. 78 indexed citations

9.

Schaufelberger, Maria, Bengt O. Eriksson, Gunnar Grimby, Peter Held, & Karl Swedberg. (1997). Skeletal muscle alterations in patients with chronic heart failure. European Heart Journal. 18(6). 971–980. 71 indexed citations

10.

Schaufelberger, Maria, Bengt O. Eriksson, Gunnar Grimby, Peter Held, & Karl Swedberg. (1995). Skeletal muscle fiber composition and capillarization in patients with chronic heart failure: Relation to exercise capacity and central hemodynamics. Journal of Cardiac Failure. 1(4). 267–272. 53 indexed citations

11.

Held, Peter & Karl Swedberg. (1987). Haemodynamic Effects of Felodipine in Congestive Heart Failure. Drugs. 34(Supplement 3). 81–84. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact